Taro Pharmaceutical Industries Ltd

VANGUARD GROUP INC

Report date

3/31/2024

Quarter

2024 Q1

Filed

5/10/2024

Shares

53,729

Value ($000)

2,275

Weight

0.0%

2019 Q4 - 2024 Q1 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q1	5/10/2024	2,275	0.0%	53,729	3/31/2024
2023 Q4	3/11/2024	2,124	0.0%	50,840	12/31/2023
2023 Q3	12/18/2023	1,812	0.0%	48,052	9/30/2023
2023 Q2	8/14/2023	1,781	0.0%	46,959	6/30/2023
2023 Q1	7/14/2023	327	0.0%	13,447	3/31/2023
2022 Q4	2/10/2023	390	0.0%	13,437	12/31/2022
2022 Q3	11/14/2022	411	0.0%	13,737	9/30/2022
2022 Q2	8/12/2022	497	0.0%	13,737	6/30/2022
2022 Q1	5/13/2022	564	0.0%	13,037	3/31/2022
2021 Q4	2/14/2022	582	0.0%	11,604	12/31/2021
2021 Q3	11/12/2021	714	0.0%	11,223	9/30/2021
2021 Q2	8/13/2021	807	0.0%	11,223	6/30/2021
2021 Q1	5/14/2021	1,010	0.0%	13,707	3/31/2021
2020 Q4	2/12/2021	856	0.0%	11,657	12/31/2020
2020 Q3	11/16/2020	263	0.0%	4,806	9/30/2020
2020 Q2	8/14/2020	318	0.0%	4,781	6/30/2020
2020 Q1	5/15/2020	269	0.0%	4,388	3/31/2020
2019 Q4	2/14/2020	373	0.0%	4,239	12/31/2019